Covered recipient · General Payments record
AUDRA DEARDORF
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$536.26
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $403.69 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $119.64 | 1 |
| Exact Sciences Corporation | $68.65 | 4 |
| Amgen Inc. | $44.80 | 3 |
| PFIZER INC. | $38.29 | 2 |
| Lilly USA, LLC | $37.34 | 2 |
| Abbott Laboratories | $36.24 | 2 |
| GlaxoSmithKline, LLC. | $33.96 | 2 |
| Novo Nordisk AS | $24.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.49 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125082287 | CMS |
| Abbott Laboratories | $18.75 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125082289 | CMS |
| Amgen Inc. | $13.72 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115560154 | CMS |
| Amgen Inc. | $16.48 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117538414 | CMS |
| Amgen Inc. | $14.60 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115560162 | CMS |
| Exact Sciences Corporation | $17.53 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114630687 | CMS |
| Exact Sciences Corporation | $17.13 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114630693 | CMS |
| Exact Sciences Corporation | $16.18 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114630699 | CMS |
| Exact Sciences Corporation | $17.81 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114630705 | CMS |
| GlaxoSmithKline, LLC. | $17.67 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116402335 | CMS |
| GlaxoSmithKline, LLC. | $16.29 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116660713 | CMS |
| Lilly USA, LLC | $20.02 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135572235 | CMS |
| Lilly USA, LLC | $17.32 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135582324 | CMS |
| Novo Nordisk Inc | $24.77 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100386789 | CMS |
| PFIZER INC. | $19.30 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131510985 | CMS |
| PFIZER INC. | $18.99 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131505477 | CMS |
| Phathom Pharmaceuticals, Inc. | $119.64 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151159770 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.